Recruiting a transcription factor in the liver to prevent atherosclerosis

被引:4
作者
Attie, Alan D. [1 ]
机构
[1] Univ Wisconsin Madison, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA
关键词
LIPID-PEROXIDATION; LIPOPROTEINS; CLEARANCE; LESIONS;
D O I
10.1172/JCI154677
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hypertriglyceridemia is associated with obesity, diabetes, and atherosclerosis. While lipoprotein lipase (LPL) hydrolyzes triglyceride (TG) cargo into remnant lipoproteins with atherogenic properties, how remnant lipoprotein clearance relates to atherosclerosis in people with diabetes remains unclear. In this issue of the JCI, Shimizu-Albergine et al. examined the effects of the basic leucine zipper transcription factor CREBH, which induces genes that activate LPL in mouse models of type I diabetes. Overexpression of a CREBH fragment reduced apolipoprotein C3 (APOC3) levels, which reduced plasma TGs. Notably, the TGs were lowered by a mechanism that was independent of LPL, and atherosclerosis was alleviated by enhanced lipoprotein remnant clearance as opposed to increased lipolysis of TG-rich lipoprotein precursors. A proinflammatory mechanism likely underlies the atherogenicity of remnant lipoproteins. These findings suggest that modifying CREBH expression in the liver may ameliorate atherosclerosis and, perhaps, other diabetes complications.
引用
收藏
页数:4
相关论文
共 21 条
[1]   RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity [J].
Abedini, Andisheh ;
Cao, Ping ;
Plesner, Annette ;
Zhang, Jinghua ;
He, Meilun ;
Derk, Julia ;
Patil, Sachi A. ;
Rosario, Rosa ;
Lonier, Jacqueline ;
Song, Fei ;
Koh, Hyunwook ;
Li, Huilin ;
Raleigh, Daniel P. ;
Schmidt, Ann Marie .
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02) :682-698
[2]   Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models [J].
Basu, Debapriya ;
Bornfeldt, Karin E. .
FRONTIERS IN ENDOCRINOLOGY, 2020, 11
[3]   Innate sensing of oxidation-specific epitopes in health and disease [J].
Binder, Christoph J. ;
Papac-Milicevic, Nikolina ;
Witztum, Joseph L. .
NATURE REVIEWS IMMUNOLOGY, 2016, 16 (08) :485-497
[4]   Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease [J].
Crosby, Jacy ;
Peloso, Gina M. ;
Auer, Paul L. ;
Crosslin, David R. ;
Stitziel, Nathan O. ;
Lange, Leslie A. ;
Lu, Yingchang ;
Tang, Zheng-zheng ;
Zhang, He ;
Hindy, George ;
Masca, Nicholas ;
Stirrups, Kathleen ;
Kanoni, Stavroula ;
Do, Ron ;
Jun, Goo ;
Hu, Youna ;
Kang, Hyun Min ;
Xue, Chenyi ;
Goel, Anuj ;
Farrall, Martin ;
Duga, Stefano ;
Merlini, Pier Angelica ;
Asselta, Rosanna ;
Girelli, Domenico ;
Olivieri, Oliviero ;
Martinelli, Nicola ;
Yin, Wu ;
Reilly, Dermot ;
Speliotes, Elizabeth ;
Fox, Caroline S. ;
Hveem, Kristian ;
Holmen, Oddgeir L. ;
Nikpay, Majid ;
Farlow, Deborah N. ;
Assimes, Themistocles L. ;
Franceschini, Nora ;
Robinson, Jennifer ;
North, Kari E. ;
Martin, Lisa W. ;
DePristo, Mark ;
Gupta, Namrata ;
Escher, Stefan A. ;
Jansson, Jan-Hakan ;
Van Zuydam, Natalie ;
Palmer, Colin N. A. ;
Wareham, Nicholas ;
Koch, Werner ;
Meitinger, Thomas ;
Peters, Annette ;
Lieb, Wolfgang .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (01) :22-31
[5]   Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models [J].
Egana-Gorrono, Lander ;
Lopez-Diez, Raquel ;
Yepuri, Gautham ;
Ramirez, Lisa S. ;
Reverdatto, Sergey ;
Gugger, Paul F. ;
Shekhtman, Alexander ;
Ramasamy, Ravichandran ;
Schmidt, Ann Marie .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
[6]   Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice [J].
Foley, Erin M. ;
Gordts, Philip L. S. M. ;
Stanford, Kristin I. ;
Gonzales, Jon C. ;
Lawrence, Roger ;
Stoddard, Nicole ;
Esko, Jeffrey D. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (09) :2065-2074
[7]   Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia [J].
Gaudet, Daniel ;
Alexander, Veronica J. ;
Baker, Brenda F. ;
Brisson, Diane ;
Tremblay, Karine ;
Singleton, Walter ;
Geary, Richard S. ;
Hughes, Steven G. ;
Viney, Nicholas J. ;
Graham, Mark J. ;
Crooke, Rosanne M. ;
Witztum, Joseph L. ;
Brunzell, John D. ;
Kastelein, John J. P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (05) :438-447
[8]   Genetics of hypertriglyceridemia and atherosclerosis [J].
Gill, Praneet K. ;
Dron, Jacqueline S. ;
Hegele, Robert A. .
CURRENT OPINION IN CARDIOLOGY, 2021, 36 (03) :264-271
[9]   Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society [J].
Ginsberg, Henry N. ;
Packard, Chris J. ;
Chapman, M. John ;
Boren, Jan ;
Aguilar-Salinas, Carlos A. ;
Averna, Maurizio ;
Ference, Brian A. ;
Gaudet, Daniel ;
Hegele, Robert A. ;
Kersten, Sander ;
Lewis, Gary F. ;
Lichtenstein, Alice H. ;
Moulin, Philippe ;
Nordestgaard, Borge G. ;
Remaley, Alan T. ;
Staels, Bart ;
Stroes, Erik S. G. ;
Taskinen, Marja-Riitta ;
Tokgozoglu, Lale S. ;
Tybjaerg-Hansen, Anne ;
Stock, Jane K. ;
Catapano, Alberico L. .
EUROPEAN HEART JOURNAL, 2021, 42 (47) :4791-+
[10]   ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors [J].
Gordts, Philip L. S. M. ;
Nock, Ryan ;
Son, Ni-Huiping ;
Ramms, Bastian ;
Lew, Irene ;
Gonzales, Jon C. ;
Thacker, Bryan E. ;
Basu, Debapriya ;
Lee, Richard G. ;
Mullick, Adam E. ;
Graham, Mark J. ;
Goldberg, Ira J. ;
Crooke, Rosanne M. ;
Witztum, Joseph L. ;
Esko, Jeffrey D. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (08) :2855-2866